These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7689104)

  • 1. Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.
    Howell LL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):894-903. PubMed ID: 7689104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic caffeine administration on respiration and schedule-controlled behavior in rhesus monkeys.
    Howell LL; Landrum AM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):190-9. PubMed ID: 9336324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of hypoxia-induced increases in ventilation by adenosine antagonists in rhesus monkeys.
    Howell LL; Landrum AM
    Life Sci; 1995; 57(8):773-83. PubMed ID: 7637551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenosine agonists on ventilation during hypercapnia, hypoxia and hyperoxia in rhesus monkeys.
    Howell LL
    J Pharmacol Exp Ther; 1993 May; 265(2):971-8. PubMed ID: 8496837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
    Howell LL; Byrd LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):432-9. PubMed ID: 8229772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys.
    Howell LL; Morse WH; Spealman RD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):786-91. PubMed ID: 2395111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and pharmacological modulation of respiration in rhesus monkeys.
    Howell LL; Landrum AM
    J Exp Anal Behav; 1994 Jul; 62(1):57-72. PubMed ID: 8064213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys.
    Howell LL; Bergman J; Morse WH
    J Pharmacol Exp Ther; 1988 Apr; 245(1):364-72. PubMed ID: 2834543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of caffeine on ventilation during acute and chronic nicotine administration in rhesus monkeys.
    Howell LL
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1085-94. PubMed ID: 7791079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
    Choi OH; Shamim MT; Padgett WL; Daly JW
    Life Sci; 1988; 43(5):387-98. PubMed ID: 2456442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interactions between selective pharmacological inhibitors of phosphodiesterase isozyme families PDE III and PDE IV to attenuate proliferation of rat vascular smooth muscle cells.
    Pan X; Arauz E; Krzanowski JJ; Fitzpatrick DF; Polson JB
    Biochem Pharmacol; 1994 Aug; 48(4):827-35. PubMed ID: 7521642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.
    Holtzman SG
    J Pharmacol Exp Ther; 1996 May; 277(2):739-46. PubMed ID: 8627553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors.
    Rabe KF; Tenor H; Dent G; Schudt C; Nakashima M; Magnussen H
    Am J Physiol; 1994 May; 266(5 Pt 1):L536-43. PubMed ID: 7515580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
    Hatzelmann A; Tenor H; Schudt C
    Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC; Anderson N; Peachell PT
    Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory effects of opioid full and partial agonists in rhesus monkeys.
    Liguori A; Morse WH; Bergman J
    J Pharmacol Exp Ther; 1996 Apr; 277(1):462-72. PubMed ID: 8613955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors.
    Wachtel H
    J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of phosphodiesterase in mediating the effect of protein kinase C on cyclic AMP accumulation upon kappa-opioid receptor stimulation in the rat heart.
    Bian JS; Zhang WM; Pei JM; Wong TM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1065-70. PubMed ID: 10688624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.